These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Search MEDLINE/PubMed


  • Title: Electroconvulsive therapy for the treatment of clozapine nonresponders suffering from schizophrenia--an open label study.
    Author: Kho KH, Blansjaar BA, de Vries S, Babuskova D, Zwinderman AH, Linszen DH.
    Journal: Eur Arch Psychiatry Clin Neurosci; 2004 Dec; 254(6):372-9. PubMed ID: 15538604.
    Abstract:
    OBJECTIVE: This open label study describes the efficacy of electroconvulsive therapy (ECT) as adjunctive treatment in clozapine nonresponders suffering from schizophrenia. METHOD: The results of clozapine and ECT treatment in 11 clozapine nonresponders suffering from schizophrenia are reported in terms of remission and relapse. RESULTS: Eight patients had a remission with this combination treatment. After remission of symptoms five patients had a relapse. Three of the five patients who relapsed had a second successful ECT course and remained well with maintenance ECT and clozapine. No evidence for adverse effects was found. CONCLUSION: Adjunctive ECT can be efficacious in clozapine nonresponders suffering from schizophrenia.
    [Abstract] [Full Text] [Related] [New Search]